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Abstract 
Alzheimer’s disease is developing proportionally with the increased aging of the worlds’ po-
pulation. To this date there are no curative treatments, but finding ways treat the disease to 
lessen the burden of the symptoms could be crucial for these patients’ quality of life. An inc-
reasing number of studies have looked at non-pharmacological approaches to treat Alzhei-
mer’s disease, but there is a lack of high-quality studies in this topic of research. The current 
thesis served as a pilot study for the Alzheimer and Music Therapy (ALMUTH) project, pro-
viding preliminary data on how physical performance and hippocampal volume affects AD 
patients and their overall well-being. Twelve AD patients were screened at the Haukeland 
University hospital. Hippocampal volumetry and total intracranial volume was extracted with 
automated segmentation using the FreeSurfer software package. Physical performance was 
measured by the Short Physical Performance Battery. The Mini-Mental State Examination, 
Geriatric Depression Scale and Activities of Daily Living served as cognitive measures. There 
was found a moderate, albeit non-significant relationship between physical performance and 
hippocampal volume, and patients with higher hippocampal volume showed significantly less 
depressive symptoms. Patients with better physical performance also reported that performing 
daily activities was easier. These preliminary findings suggest a relationship between physical 
performance and hippocampal volume in Alzheimer’s disease patients and serve as proof-of-
concept for the ALMUTH study. The data show encouraging prospects for investigating the 
relationship between physical performance, hippocampal volume, and Alzheimer’s disease at 
a greater scale. 
Key words: Alzheimer’s disease, physical performance, hippocampal volume, cognition, daily func-
tioning, depression, FreeSurfer 
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Sammendrag  
Alzheimers sykdom utvikler seg proporsjonalt med økningen av en aldrende verdensbefolk-
ning. Det finnes ingen kurative behandlinger for sykdommen, og å finne måter å behandle 
sykdommen på eller symptomene disse pasientene opplever, kan være avgjørende for deres 
livskvalitet. Et økende antall studier har sett på medikamentfrie tilnærminger i forbindelse 
med behandling av Alzheimers, men det er mangel på studier av høy kvalitet på dette områ-
det. Denne avhandlingen har fungert som en pilotstudie for Alzheimer og Musikkterapi 
(ALMUTH) prosjektet, og gir foreløpige data om hvordan fysisk funksjon og hippocampalt 
volum påvirker Alzheimers pasienter og deres generelle velvære. Tolv personer diagnostisert 
med Alzheimers ble testet på Haukeland Universitetssykehus. Volum av hippocampus og to-
talt intrakranielt volum ble ekstrahert med automatisk segmentering ved hjelp av program-
varepakken FreeSurfer. Fysisk funksjon ble målt med Short Physical Performance Battery. 
Mini-Mental State Examination, Geriatrisk Depresjonsskala, og Aktiviteter i Dagliglivet fun-
gerte som kognitive måleinstrumenter. Det var et moderat, ikke-signifikant forhold mellom 
fysisk funksjon og volum av hippocampus. Pasienter med større hippocampalt volum viste 
signifikant mindre depressive symptomer, og de som hadde bedre fysisk funksjon fant det 
enklere å utføre aktiviteter i dagliglivet. Disse foreløpige funnene viser en assosiasjon mellom 
fysisk funksjon og hippocampalt volum hos Alzheimer’s pasienter, og fungerer som ‘proof-
of-concept’ for ALMUTH-studien. Dataene viser gode muligheter for å undersøke forholdet 
mellom fysisk funksjon, volum av hippocampus, og Alzheimers sykdom i en større skala. 
Nøkkelord: Alzheimers sykdom, fysisk funksjon, hippocampalt volum, kognisjon, depresjon, daglig 
funksjon, FreeSurfer  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Introduction 
Dementia is an overall term for a range of symptoms associated with memory loss and 
progressive intellectual deficit in elderly. By this date it is approximated that around 70.000 
individuals suffer from dementia in Norway, and with relatives and carers included, about 
250.000 people in Norway are affected by the disease (Helse og omsorgsdepartementet, 
2012). Alzheimer’s disease (AD) is the most common form of dementia, affecting about 60% 
of all patients (Lobo et al., 2000). Hebert and colleagues (2003) predicted that the prevalence 
of AD will more than double in 40 years, making the disease a major global health concern. 
Cognitive decline is common in AD and typical symptoms of the disease include hallucina-
tions, memory loss, not understanding one’s surroundings etc., strongly affecting the well-be-
ing of AD patients. In a systematic review of non-pharmacological approaches to treating de-
mentia (Hulme, Wright, Crocker, Oluboyede, & House, 2010), the authors pointed out that, 
after music therapy, exercise was defined as the second most effective treatment to dementia. 
However, their overall conclusion was that there are too few high-quality studies to make a 
good assessment. Moreover, a study comparing cardiovascular fitness and brain atrophy in 
normal aging vs. early AD patients showed that higher fitness levels in were associated with 
less brain atrophy dependent on dementia severity and age (Burns et al., 2008). 
The hippocampus is usually one of the first brain structures affected by AD, and tends 
to atrophy at a steady rate once a patient is affected by the disease (van der Flier et al., 2005). 
Whether there is a relationship between the hippocampal volume (HCV) of AD patients and 
their physical performance is an interesting issue there is little research on to this date. Greater 
brain atrophy, and thereby lower levels of cognitive functioning, is a precursor with those who 
suffer from AD. To this day, there is no cure for AD, albeit some medication may relieve the 
symptoms these patients suffer from. Because cognitive decline tends to correlate with the 
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patient’s quality of life, finding a satisfactory, non-medical treatment can thus be extremely 
valuable for the well-being of these patients. If the current thesis finds encouraging results, 
the relationship between AD, hippocampal volume and physical performance will be explored 
further at a greater scale by the Alzheimer and Music Therapy (ALMUTH) research group at 
the Institute for Biological and Medical Psychology (IBMP) and Haukeland University Hos-
pital in Bergen, Norway.  
Alzheimer’s Disease 
AD was first described by the neurologist Alois Alzheimer (1864-1915) as a type of 
dementia appearing before the age of 65 (Alzheimer, 1907; Stelzmann, Schnitzlein, & Mur-
tagh, 1995). The disease is characterized by deficits in memory and general cognitive func-
tioning, but also by difficulty in performing daily activities. As the disease progresses, me-
mory loss and confusion grow worse and ultimately, AD patients become entirely dependent 
on others for their care (National Institute on Aging, 2016). The frequency of AD is higher 
between the ages of 85-90 (Rocca et al., 1991), but according to Breitner and colleagues 
(1999), people reaching that age without showing symptoms are less likely to develop the 
disease altogether. This indicates that AD is, in fact, a brain disorder, and does not come from 
normal wear and tear in the brain as initially assumed. Alzheimer’s disease is thereby a neu-
rodegenerative disorder, characterized by alteration in neurogenesis, abnormal formation of 
tau-protein positive neurofibrillary tangles in neurons, abnormal extracellular accumulation of 
amyloid in senile and diffuse plaques, and cortical atrophy with associated synapse and neu-
ron loss (Crews & Masliah, 2010; Masliah & Salmon, 1999).  
Brain atrophy. Medial temporal lobe (MTL) structures such as the entorhinal cortex 
and hippocampus are usually the first to be affected by these neuropathological changes. 
From there, the atrophy advances to structures such as the basal forebrain and temporal and 
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frontal lobe association cortices in the lateral and anterior cortical areas of the brain, and final-
ly the association cortices in the occipital and parietal lobe (Braak & Braak, 1991). The pri-
mary motor- and sensory cortex typically remain free from AD pathology (Pearson, Esiri, 
Hiorns, Wilcock, & Powell, 1985). As most subcortical areas (e.g., basal ganglia, thalamus) 
are relatively spared, AD is often classified as a classic form of diffuse cortical dementia. 
Utilizing structural magnetic resonance imaging (MRI) to asses brain atrophy has been 
shown to be a valid marker of AD-related neurodegeneration with post-mortem histology 
(Bobinski et al., 1999; Whitwell et al., 2012). In recent years, MRI-derived markers of neu-
rodegeneration can currently be used to track disease progression in clinical trials and to sup-
port a clinical diagnosis of AD (Dubois et al., 2010; McKhann et al., 2011). Through the use 
of high-resolution MRI, the neurodegeneration of specific cortical and subcortical grey matter 
(in terms of morphological changes, volume loss, and cortical thinning) can be accurately 
quantified in vivo. Using diffusion MRI sequences, the white matter (WM) structural damage 
can also be estimated, and atrophy throughout the brain in one of many markers for AD. 
Because the brain is plastic, it changes with age and the hippocampus is no exception. 
However, in AD, the rate of hippocampal atrophy has been seen in numerous studies to be 
greater than that of a normal aging brain (Jack et al., 1997; Kesslak, Nalcioglu, & Cotman, 
1991; Scheltens et al., 1992; Seab et al., 1988). Memory impairment is characteristic in early 
symptoms of AD, and it has been consistently reported that structures like the medial tempo-
ral lobe, and particularly the hippocampal formation is one of the earliest macroscopical hall-
marks of AD. The hippocampus has therefore been named as one of the core biomarkers of 
AD (Albert et al., 2011; Dubois et al., 2010; McKhann et al., 2011; Sperling et al., 2011), and 
because of its significant role, earlier articles have gone so far as to call the disease «hippo-
campal dementia» (Ball et al., 1985; Hyman, Van Hoesen, Damasio, & Barnes, 1984). The 
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loss of hippocampal volume has been found in numerous MRI studies worldwide, and hippo-
campal volume has been found to be reduced by 15-30% already at the mild cognitive stage 
(van der Flier et al., 2005), and by 10-15% in patients with the amnesic variant of mild cogni-
tive impairment (MCI) (Shi, Liu, Zhou, Yu, & Jiang, 2009). According to Jack and colleagues 
(2000) the annual rate of the hippocampus in healthy elderly adults is at 1.73%, whilst the an-
nual rate of AD patients was measured to be 3.5%/yr. AD is described as a memory deficit 
disease, and the rapid and significant loss of hippocampal tissue is thought to be the cause of 
the deficit.  
On a cellular level, many factors contribute to the loss of brain tissue. Brain-Derived 
Neuropathic Factor (BDNF) is a molecule that can be found in high concentrations in both the 
cortex and the hippocampus. The BDNF molecule is critical in plasticity, cell proliferation 
and cellular analogs of memory formation, and recent studies are linking changes in the 
BDNF system to depression, hippocampal atrophy and age-related memory impairment (e.g., 
Erickson et al., 2010). A study performed by Nagahara and colleagues (2009) on rodents 
found that BDNF administration showed broad neuroprotective effects, showing that BDNF 
therapeutic delivery could potentially serve as a therapy for AD. Because BDNF is widely 
expressed in the entorhinal cortex, and anterogradely trafficked into the hippocampus (Yan et 
al., 1997), it is hypothesized to underlie learning (Kaplan & Miller, 2000). A possibility is that 
the molecule could be an independent factor in hippocampal atrophy because of its reduction 
in the entorhinal cortex and hippocampus in AD pathology (Connor et al., 1997; Hock, Heese, 
Hulette, Rosenberg, & Otten, 2000; Narisawa-Saito, Wakabayashi, Tsuji, Takahashi, & Nawa, 
1996). Although intriguing, neither this thesis nor the ALMUTH project will look at the 
BDNF molecule, but it is worth noting which underlying processes might lie underneath hip-
pocampal atrophy. 
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Physical Activity 
Beneficial effects of exercise on cognitive functioning has been demonstrated in nu-
merous animal models, and more recently in an increasing number of clinical studies on the 
elderly population (Erickson & Kramer, 2009; Fillit et al., 2002; Kramer, Erickson, & Col-
combe, 2006). Research with results mostly derived from animal studies have found that 
mechanisms that potentially have a salutary effect from exercise include neuroendocrine re-
sponse to stress, neuroinflammation, neuronal survivability and function, and brain amyloid 
burden (Adlard, Perreau, Pop, & Cotman, 2005; Carro, Trejo, Busiguina, & Torres-Aleman, 
2001; Cotman, Berchtold, & Christie, 2007; Fordyce & Farrar, 1991; Isaacs, Anderson, Al-
cantara, Black, & Greenough, 1992; Nagahara et al., 2009; Nichol et al., 2008; Parachikova, 
Nichol, & Cotman, 2008; Sasse et al., 2008; Um et al., 2008; Van Praag, Shubert, Zhao, & 
Gage, 2005). Interestingly, exercise has been shown to have positive effects on physiological 
processes that can increase the risk of developing AD when compromised, namely cardiovas-
cular health and glucoregulation (Craft, 2005; Gasparini & Xu, 2003; Helzner et al., 2009; 
Kuusisto et al., 1997).  
There are several documented cognitive benefits associated with regular exercise and 
activity. Colcombe and Kramer (2003) did a meta-analytic study on the fitness effects of older 
adults’ cognitive function. The authors mainly focused on the effects of aerobic fitness and 
intervention studies and found that fitness training had the most robust, albeit selective, bene-
fits for cognition, where the biggest effect was found for the executive functioning processes 
(i.e., working memory, planning, multi-tasking, scheduling etc.). These findings are specifi-
cally intriguing considering that the pathology of executive functioning is the same as where 
AD patients experience the greatest and earliest atrophy. This might suggest that processes 
showing substantial age-related atrophy are amendable to change. Thus, the magnitude of the 
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effects of exercise seems to be substantial and should be taken into account when looking for 
effective intervention strategies for AD patients. 
Health benefits from exercise. Physical activity throughout one’s lifespan has been 
associated with the reduction of a number of mental (e.g., anxiety, depression) and physical 
(e.g., breast and colon cancer, cardiovascular disease, obesity) disorders (US Department of 
Health and Human Services, 2000). Norwegian Directorate of Health recommends 150 minu-
tes of moderate activity a week, or 75 minutes of high intensity (Karlsson, Ståhle, Tranquist, 
& Aadland, 2009). However, only 1 out of 3 Norwegians fulfill these requirements, and 60% 
of the average Norwegian day is spent in inactivity (Hansen et al., 2015). According to a re-
port from 2012, physical inactivity is the cause of 6-10% of the major non-communicable 
diseases such as coronary heart disease, breast and colon cancer, and type II diabetes world-
wide (Lee, Shiroma, Lobelo, & Puska, 2012). Whether inactivity is a direct cause of AD has 
not yet been established, but it appears that there is a strong relationship between the two that 
is worth investigating. 
Effective strategies to delay the onset of AD and the progression of this potentially 
devastating disease is being researched worldwide. A recent retrospective case-control study 
(Friedland et al., 2001) showed that patients with AD were generally less active in their 
midlife (both physically and intellectually), and that inactivity was associated with a 250% 
increased risk of developing AD. Successful and effective prevention strategies would result 
in considerable benefits through prolonged independent life expectancy, improved quality of 
life, and reduced social burdens and economic cost. Consequently, regular physical activity, 
apart from being an important element in overall health promotion (Larson & Wang, 2004), 
might be an effective strategy for delaying the onset of dementia (Pate et al., 1995). 
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 Balance and falls. AD patients often experience falls as a result of the loss of balance. 
Falls in the elderly population is associated with major morbidity, long hospital stays, costs, 
and mortality (Siracuse et al., 2012), and research has shown that it is possible to prevent falls 
by exercising and improving physical performance. According to Bergen Municipality's re-
port “Trygg på to bein”, (Bergen Kommune, 2010), balance training and strength-building 
exercises have the best results for preventing falls. Moreover, they reported that several stud-
ies (Campbell, Robertson, Gardner, Norton, & Buchner, 1999; Helbostad, Leirfall, Moe-
Nilssen, & Sletvold, 2007; Skelton, Dinan, Campbell, & Rutherford, 2005) displayed how 
inactive seniors who had not previously experienced falls had a good effect of a one year 
training program. The training group reduced the number of falls by 30% compared with the 
control group and the effect of exercise was also greatest in the elderly with initial or estab-
lished functional failure.  
 With aging, major changes in body composition often follow. Changes such as a pro-
gressive decrease in muscle strength, mass, and quality accompanied by an increase of fat tis-
sue can negatively affect functional status (Candow & Chilibeck, 2005; Lauretani et al., 
2003). According to the «Trygg på to bein» report, muscle strength is the low-impact effect a 
muscle or muscle-group can develop. One article (Liu & Latham, 2009) suggests that it ap-
pears as if elders who exercise muscle strength become stronger and achieve better function in 
daily activities. Another study (Kalapotharakos, Michalopoulos, Tokmakidis, Godolias, & 
Gourgoulis, 2005) showed that two groups of elderly people who used to exercise did better 
on functional tests after a training intervention. According to the Bergen Municipality report, 
exercise for the elderly, as for young people, must be done 2-3 times a week with a certain 
intensity (8-12 repetitions and 3 sets) and be done for a minimum duration of 12 weeks to 
have an effect (2010). Evidently, increasing muscle composition, and thereby increasing phys-
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ical performance could substantially decrease the likelihood of falls in the elderly and with 
that, long and costly hospital stays. 
 Cardiovascular Problems. Research has increasingly demonstrated a link between the 
risk of developing dementia to cardiovascular problems (Whitmer, Gunderson, Barrett-Con-
nor, Quesenberry, & Yaffe, 2005a; Whitmer, Sidney, Selby, Johnston, & Yaffe, 2005b). Such 
risk factors include obesity, high cholesterol, diabetes, and substance abuse, mostly associated 
with smoking cigarettes. Data obtained from 8845 participants in a retrospective cohort study 
showed a 20-40% higher risk of developing dementia for individuals suffering from cardio-
vascular risk factors earlier in their life (Whitmer et al., 2005b). Data derived from longitudi-
nal studies showed that obesity has been found to be the single highest predictor of dementia, 
increasing its risk by 74% (Whitmer et al., 2005a). Furthermore, compared to participants 
with a healthy body mass index (BMI), they found that simply being overweight would in-
crease the risk of developing dementia by 35%. These studies by Whitmer and colleagues 
shows the importance of considering physical health in diagnosing patients with AD and de-
mentia, both individually and combined, as exercise and increased physical performance has 
been shown to reduce factors implemented in developing AD. 
Diabetes. Evidentially, because the risk factors of cardiovascular problems such as 
high cholesterol and obesity are associated with diabetes, individuals diagnosed with diabetes 
mellitus (DM) are possibly at a higher risk of developing dementia. Twenty percent of adults 
above the age of 65 are affected by DM and numerous cross-sectional studies have shown an 
association between DM and cognitive impairment (Croxon & Jagger, 1995; Desmond, Tate-
michi, Paik, & Stern, 1993; Grodstein, Chen, Wilson, & Manson, 2001). Thus, an association 
between AD and DM is not implausible and studies looking at the association has been car-
ried out with mixed results. A longitudinal study conducted on Catholic nuns, priests and 
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brothers found that, of the participants that had DM, 65% was at risk of developing AD (Ar-
vanitakis, Wilson, Bienias, Evans, & Bennett, 2004). Depression is also more likely to occur 
in patients with DM, and for patients with a dual diagnosis of both depression and DM, the 
risk of developing dementia is two-to-threefold (Katon et al., 2010). Exercise has been found 
to be therapeutic both for individuals with diabetes (Soman, Koivisto, Deibert, Felig, & De-
Fronzo, 1979) and for depression (Babyak et al., 2000), and there is thus reason to believe 
that an active lifestyle could be beneficial in the prevention of developing DM, and accor-
dingly AD. 
Generally, there is an extensive body of research linking exercise to beneficial out-
comes both neuropsychologically and physically. A link between cardiovascular problems and 
AD has been well established, and exercising on a regular basis seems to have a positive ef-
fect on AD-and age-related brain atrophy. Additionally DM and falls, problems often occur-
ring in the AD population, can seemingly be prevented by engaging in physical activity. There 
is thus reason to believe that not only can the quality of life be enhanced in active AD pa-
tients, but the rate at which their brain decays can evidently be slowed down. 
Hippocampal Volumetry 
This thesis is a part of the ALMUTH project at IBMP and Haukeland University Hos-
pital, and only addresses a small part of the project. The ALMUTH project will utilize, among 
other methods, the newly developed BrainAGE paradigm to determine how the brain of the 
patients differentiate from that of a healthy person in the same age group. Throughout the 
normal aging process, the brain is prone to change due to both regressive (e.g., cell death and 
atrophy) and progressive (e.g., myelination and cell growth) neuronal processes. One study 
showed that grey matter (GM) volume increases from birth until the age of four, followed by 
a continuous decline until the age of around 70 (Pfefferbaum et al., 1994). Furthermore, 
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through the very crude geometrical method for the segmentation of MRI data, Pfefferbaum 
and colleagues also found a WM increase up until the age of 20 when it plateaus. A more re-
cent study (Good et al., 2001) with 465 normal subjects between the ages of 17 and 79 sug-
gested a linear decline in GM to be prevailing in normal aging. Moreover, micro-structural 
changes in WM and local areas of GM atrophy was reported, suggesting a complex and het-
erogeneous pattern of atrophy across the adult life span. Evidence for a non-linear and region-
specific pattern of neurodegenerative age-related changes in GM volume was also reported by 
longitudinal data comparisons (Resnick, Pham, Kraut, Zonderman, & Davatzikos, 2003) and 
cross-sectional morphometric analyses (Terribilli et al., 2011). The hypothesis of normal age-
related GM decline is thus supported by these results to the phylogenetic origin of each spe-
cific brain region, with younger structures being the last to develop and mature, and thus be-
ing more vulnerable to neurodegeneration. Diseases such as AD alter brain structures in ab-
normal and diverse modes (Ashburner et al., 2003), and another study has recently provided 
additional evidence supporting this view by showing that the atrophied regions in normal-ag-
ing patients are closely related to the regions detected in AD patients (Dukart, Schroeter, 
Mueller, & the Alzheimer's Disease Neuroimaging Initiative, 2011). 
BrainAGE. In order to differentiate a pattern of brain atrophy that deviates from nor-
mal brain aging, Franke and colleagues (Franke, Luders, May, Wilke, & Gaser, 2012; Franke, 
Ziegler, Klöppel, Gaser, & for the Alzheimer's Disease Neuroimaging Initiative, 2010) devel-
oped the novel BrainAGE approach. The BrainAGE approach is based on a database of single 
time-point structural MRI data, which aggregates the multidimensional, complex aging pat-
terns across the entire brain into one single value, being the estimated brain age. This is de-
termined by applying established kernel regression methods to the MRI images. The Brain-
AGE framework applies RVR, a machine-learning pattern recognition method based on T1-
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weighed images developed by Tipping (2001) to estimate individual brain ages. The age esti-
mation accuracy did not show any improvement with non-linear kernels, thus as suggested by 
Franke and colleagues (2010) the kernel used was a polynomial of degree 1. The training pe-
riod does accordingly not need parameter optimization. The BrainAGE model is trained with 
preprocessed whole brain structural MRI data of the training sample.  
Hippocampal volume is seen as one of the core biomarkers for MCI converting to AD 
(Apostolova et al., 2006b; Devanand et al., 2007) and the BrainAGE paradigm has successful-
ly been applied to predict progression of AD (Franke & Gaser, 2012; Gaser et al., 2013; 
Löwe, Gaser, Franke, & the Alzheimer’s Disease Neuroimaging Initiative, 2016). Moreover, it 
has been successful in examining neurodevelopmental effects in children and adolescents 
(Franke et al., 2012), examine the hormonal influences and lifestyle factors (Franke, Hage-
mann, Schleussner, & Gaser, 2015; Franke, Ristow, & Gaser, 2014; Luders, Cherbuin, & Gas-
er, 2016), to determine brain-aging effects in psychiatric and non-psychiatric diseases 
(Franke, Gaser, Manor, & Novak, 2013; Koutsouleris et al., 2013), and to determine the im-
pact of long-term instrumental music making on the mature brain (Rogenmoser, Kernbach, 
Schlaug, & Gaser, 2018). There are thus promising prospects for finding interesting results by 
looking at physical performance and BrainAGE for the ALMUTH project. 
BrainAGE is ideal for the purpose of ALMUTH that will use longitudinal data, and it 
requires a sophisticated setup which is semi-proprietary. It is furthermore required to scan a 
large number of control subjects for algorithmic calibration purposes, which is not feasible for 
a thesis running over the course of one year. Therefore, for the purposes of this thesis, the 
more well-established HCV will be used, which can be computed in a standardized way using 
the FreeSurfer software package.  
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FreeSurfer. For the past 20 years, the hippocampus has been implicated in regulating 
emotion, forming memories, and in a number of neuropsychiatric diseases, such as epilepsy, 
depression, sleep disorders, schizophrenia, and dementia (Geuze, Vermetten, & Bremner, 
2005b). Because of this, trying to optimize MRI-based hippocampal volumetry through vari-
ous manual (Geuze, Vermetten, & Bremner, 2005a) and automated (Carmichael et al., 2005; 
Chupin et al., 2007; Csernansky et al., 1998; Duchesne, Pruessner, & Collins, 2002; Fischl et 
al., 2002; Ghanei, Soltanian-Zadeh, & Windham, 1998; Haller et al., 1997; Hsu et al., 2002) 
protocols has been investigated. Although throughout the literature the general understanding 
is that manual hippocampal volumetry is the ‘gold standard,’ it is dependent on rater experi-
ence and it is highly time-consuming. Therefore, several automated volumetric methods have 
been developed. The FreeSurfer (Fischl et al., 2002) software package (http://surfer.nm-
r.mgh.harvard.edu) is an observer-independent subcortical volume and segmentation tech-
nique, which provide volumes for individual subcortical nuclei from conventional MR im-
ages. The accuracy of using an automated method for labelling and volumetry of subcortical 
structures have been independently validated with respect to manual volumetric techniques, 
mainly for the hippocampus (Cherbuin, Anstey, Réglade-Meslin, & Sachdev, 2009; Dewey et 
al., 2010; Morey et al., 2009; Pardoe, Pell, Abbott, & Jackson, 2009; Shen et al., 2010; Tae, 
Kim, Lee, Nam, & Kim, 2008). The software provides completely automated parcellation of 
the cortex and of subcortical structures. It calculates individuals’ brain subvolumes by allocat-
ing a neuroanatomical label to each voxel of the MRI scan, and the allocation is based on a 
manually trained training set. Compared to most other automated measures of hippocampal 
volumetry, the FreeSurfer package is publicly available to researchers, making it a suitable 
application for the current thesis. 
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Hippocampal Volume, Physical Performance, and Cognitive Impairment 
Testing for physical performance in an Alzheimer’s Disease Population. Neu-
ropsychological tests have been developed for various clinical outcomes. Tests to identify ear-
ly clinical AD has become important to start treatment plans in the early course of the AD 
progression. Standardized tests of physical performance have been found to be predictive of 
important outcomes such as nursing home admission, hip fractures, and death. These tests are 
thus highly associated with several measures on health status and have consequently been ap-
plied to geriatric assessment setting and research increasingly (see Guralnik et al., 1994 for an 
overview). One of the most common tools to measure physical performance in population 
studies on aging is through the Short Physical Performance Battery (SPPB) (Guralnik, Fer-
rucci, Simonsick, Salive, & Wallace, 1995). The test includes chair stands tests, walking, and 
balance, and has been used in a broad spectrum of epidemiological studies on aging (Cesari et 
al., 2004; Guralnik et al., 2000; Guralnik et al., 1995; Guralnik et al., 1994; Onder et al., 
2005; Penninx et al., 2000; Rolland et al., 2006). Patients scoring low in the SPPB have been 
predicted to have a higher chance of developing a range of health outcomes: hospitalization, 
length of hospital stay, disability, nursing home admission, mobility loss, and death (Guralnik 
et al., 2000; 1994; Penninx et al., 2000; Volpato et al., 2008).  
In the Leukoaraiosis and Disability Study (LADIS), researchers aimed at determining 
the influence of age-related WM changes on several objective measures of balance and gait 
(Baezner et al., 2008). Here, they tested walking speed, balance, and used the SPPB to test 
patients mobility. They found a clear association between higher SPPB scores and individuals 
who were physically active. The presence of severe age-related WM changes was also found 
to be a significant determinant of a pathologic SPPB. Furthermore, it was found that old age, 
peripheral vascular disease, and diabetes interfered with their test on walking speed. In con-
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clusion, the researchers stated that exercise could have a protective effect in delaying disabili-
ty.  
In the literature, it is generally agreed upon that such tests of physical performance 
supplement, rather than replace, self-report measures of activity and disability. However, pati-
ents diagnosed with AD does not have the same ability to correctly self-report their exercising 
habits, physical performance, and disabilities. It is thus of great importance to find a test 
measuring these patients’ physical performance both in a reliable and valid manner. The SPPB 
has been shown to have a high test-retest reliability in several studies. In a study on the elder-
ly population in Columbia, the test-retest reliability was high at 0.87 (Gómez, Curcio, Alvara-
do, Zunzunegui, & Guralnik, 2013). This has shown to be consistent with earlier studies, such 
as in a study comparing Canadian and Brazilian populations, where the intra-observer reliabi-
lity in Canada was at 0.89 (95% CI, 0.83-0.93) and at 0.83 (95% CI, 0.73-0.89) in Brazil 
(Freire et al., 2012). The within-group correlation coefficients have been found to be between 
0.88 and 0.92 in the U.S. population (Ostir, Volpato, Fried, Chaves, & Guralnik, 2002; Volpa-
to et al., 2010). The test-retest reliability from Spanish elderly in five primary care centers 
ranged from 0.6 (95% CI, 0.35-0.70) for the balance test, and 0.8 (95% CI, 0.67-0.86) for gait 
speed (Cabrero-García et al., 2012). The SPPB has thus been tested and shown to be reliable 
in various populations, which can increase its clinical application around the world.  
Physical performance and brain atrophy. As previously mentioned, an active life-
style may contribute positively to both cognitive and psychological processes. However, re-
cent evidence has suggested that exercise may also moderate AD-related brain atrophy. In a 
study on cardiorespiratory fitness and brain atrophy in AD patients, Burns and colleagues 
(2008) demonstrated that higher levels of fitness in early AD patients were associated with 
less brain atrophy, independent of dementia severity and age. A more recent study (Niemann, 
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Godde, & Voelcker-Rehage, 2014) looked at, not only the effects of cardiovascular exercise 
on the hippocampus but also coordinative exercise. The effects of motor fitness and coordina-
tion training have shown to for example facilitate synaptic re-construction and growth (synap-
togenesis; Anderson et al., 1994; Black, Isaacs, Anderson, Alcantara, & Greenough, 1990). 
There were also evidence for motor fitness (e.g., movement speed, balance, fine 
coordination), but not metabolic fitness (muscle strength and cardiovascular fitness), being 
associated with hippocampal volume (Niemann et al., 2014). 
Most research on the neuropathological effects of exercise has been conducted on 
animals, and it is thus difficult to draw any reliable conclusions on whether the effects apply 
to humans as well. Nevertheless, there is an extensive animal literature indicating that exerci-
se produces increases in insulin-like growth factor and nerve growth factor (for review see 
Ang & Gomez-Pinilla, 2007 and; Cotman & Berchtold, 2002). In the BDNF molecule as 
mentioned previously (Neeper, Góauctemez-Pinilla, Choi, & Cotman, 1995; Vaynman, Ying, 
& Gomez-Pinilla, 2004), exercise promotes angiogenesis (Gómez-Pinilla, So, & Kesslak, 
1998), neurogenesis (Van Praag, Christie, Sejnowski, & Gage, 1999; Van Praag et al., 2005), 
and synaptic plasticity and expression of enzymes that underlie metabolism and glucose use 
(for review see Cotman et al., 2007). These effects have primarily been observed in the hip-
pocampal regions of rats, and some have reported similar effects in the amygdala (Green-
wood, Strong, Foley, & Fleshner, 2009) and the entorhinal cortex (Stranahan, Khalil, & 
Gould, 2007). A few clinical trials have shown favorable effects of exercise on memory 
(Erickson et al., 2009; Lautenschlager et al., 2008), though most research supporting a me-
mory benefit derives from animal research (Parachikova et al., 2008; Radák et al., 2001; Van 
Praag et al., 2005; Vaynman et al., 2004). 
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Age-related changes in the BDNF system could potentially play a role in the loss of 
tissue in the hippocampus. The effect of exercise on BDNF levels have shown to be positive 
in both animal and human studies, and in a review by Erickson, Miller, and Roecklein (2012) 
it was concluded that decreases in BDNF protein expression are associated with increased 
rates of geriatric depression and poorer hippocampal function. Results of prospective brain 
imaging (2006) and cross-sectional (2003) studies in humans performed by Colcombe and 
colleagues suggests that in cognitively healthy older adults, increased aerobic fitness is related 
to reduced age-related atrophy and increased perfusion in brain regions that support memory 
processes and executive control. However, most processes are vulnerable to aging (Colcombe 
& Kramer, 2003; Daniels, Toth, & Jacoby, 2006). A recent intervention study looked at the 
effects of dancing and traditional healthy fitness training on hippocampal plasticity and bal-
ance in healthy seniors (Rehfeld et al., 2017). An increase in HCV was found for both fitness 
groups. Hippocampal atrophy is one of the most prominent markers in AD pathology, but the 
hippocampus is also affected by normal aging processes resulting in deficits in learning, 
memory, and spatial navigation at old age (Barnes et al., 2009; Driscoll et al., 2003). The find-
ings of Rehfeld and colleagues (2017) linking hippocampal volume increases (mainly in the 
left hippocampus; areas CA1, CA2, and subiculum, respectively) to exercise are thus very 
interesting, despite the experiment having a low number of participants and a relatively high 
drop-out rate. Nonetheless, the literature shows a general agreement of physical performance 
being linked to HCV and whether this volume can increase or not, remains to be investigated 
thoroughly. However, studies finding a clear link through greater scale interventional studies 
such as the ALMUTH project could be of great significance, and pilot data from this thesis 
will shown an indication on whether to spend time and resources on a full-scale investigation.  
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H1: There is a positive correlation between hippocampal volume and physical perfor-
mance, i.e., greater hippocampal volume in AD patients will be positively associated with 
higher scores on the SPPB. 
Cognitive impairment. Deficits in memory and attention often occur before a clinical 
diagnosis of AD. Global cognition and executive functioning typically show significant asso-
ciations with broader neurological measures: ventricular enlargement, whole brain atrophy, 
and cortical thickness across multiple brain regions (Dickerson, Wolk, & the Alzheimer's Dis-
ease Neuroimaging Initiative, 2011; Evans et al., 2010; Nho et al., 2012; Stonnington et al., 
2010). Additionally, executive functioning task performance and the regions of the brain that 
support them may also contribute to episodic memory ability (Chang et al., 2009). Several 
studies have also found a link between physical activity and the risk of developing cognitive 
decline (Weuve et al., 2004; Yaffe, Barnes, Nevitt, Lui, & Covinsky, 2001).  
One test developed to test cognition is the Mini-Mental State Examination (MMSE). It 
is commonly used in medicine and psychology for screening dementia, and during the 10-
minute test, several cognitive domains are tested such as arithmetics, memory, and orienta-
tion. A score of 27 or above is seen as being within the normal range. A score in the interval 
20-26 indicates MCI, 10-19 indicates moderate cognitive impairment, and a score of under 10 
indicates severe cognitive impairment. It was developed by Folstein and colleagues (1975) to 
distinguish between psychiatric and neurological patients and is probably the most popular 
measure to screen for cognitive impairment to this day. The test has shown to have good test-
retest reliability (Folstein et al., 1975; O'connor et al., 1989; Tombaugh & McIntyre, 1992), as 
well as sufficient specificity (0.92) and sensitivity (0.86) in ‘organic mental disorders’ as de-
fined by the authors (O'connor et al., 1989). The test has been criticized numerous times (e.g., 
Feher et al., 1992) and is currently under the scope in a plagiarism case. Nevertheless, it main-
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tains its significant role in the assessment of the of therapeutic agents on cognitive function 
(Berger, Fratiglioni, Winblad, & Bäckman, 2005; Meyer, Xu, Thornby, Chowdhury, & Quach, 
2002; Tierney, Szalai, Dunn, Geslani, & McDowell, 2000), and in the follow-up (Meyer et al., 
2002). The MMSE is a very important test for the current thesis as it can give insight into how 
far in the progression of the disease the AD patients are and how much cognitive impairment 
they are experiencing. 
H2: There will be a positive correlation between MMSE and HCV, suggesting that bet-
ter memory and attention correlates with greater hippocampal volume.  
H3: Greater physical performance will be positively correlated with higher scores of 
the MMSE, i.e., patients scoring higher on the SPPB will have better cognition. 
Depressive symptoms. Depression is an important topic of interest in geriatric pa-
tients and can have a significant role in AD patients’ welfare. Moreover, good mental health 
can influence the length of which patients are able to live at home. The Geriatric Depression 
Scale (GDS) (Brink et al., 1982; Yesavage et al., 1982) is one of the most used assessment 
scales in the evaluation of depression in the elderly population and is a brief self-report ques-
tionnaire which includes a set of 30 yes/no questions. It was the first test developed specifi-
cally for older adults, in some part by eliminating sexual and somatic complaints, which often 
appears on other depression scales. The test taps behavioral and affective (but not vegetative) 
symptoms of depression. Its concurrent validity and reliability has been established next to 
psychiatric diagnoses or other well-established diagnostic instruments with healthy, active 
elderly community residents and patients receiving psychiatric or medical in- or outpatient 
treatment (Koenig, Meador, Cohen, & Blazer, 1988; Norris, Gallagher, Wilson, & Winograd, 
1987; Rapp, Parisi, & Walsh, 1988). 
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It has been estimated that up to 87% of older adults with AD suffer from depression 
(Carpenter, Ruckdeschel, Ruckdeschel, & Haitsma, 2003), and exercise has been shown to be 
an effective treatment in reducing depressive symptoms for normal older adults, cognitively 
intact older adults with depression, and older adults with medical illnesses (Blumenthal et al., 
1999; Mather et al., 2002; Mazzeo et al., 1998; North, McCullagh, & Tran, 1990; Singh, 
Clements, & Fiatarone, 1997). Little is known about the effects on exercise with regard to de-
pressive symptoms in AD patients, but some studies have started to investigate this relation-
ship. Williams and Tappen (2008) did a 16-week intervention study where they measured the 
reduction of depression in AD patients after comprehensive exercise, supervised walking, or 
social conversation. They found that exercise as a behavioral approach to treating depression 
had a clear benefit for nursing home residents diagnosed with moderate to severe AD. The 
effects of both social conversation and supervised walking did also yield a positive result, al-
beit the effect of comprehensive exercise was superior. Considering the prevalence of depres-
sion amongst the elderly, this offers evidence for the improvement of life quality for those AD 
patients who exercise on a regular basis. 
Depression can result in more adverse consequences for both patients and their caregi-
vers (Starkstein, Jorge, Mizrahi, & Robinson, 2005). Some papers have even tried to establish 
that because in many cases, depression precedes clinical diagnosis of AD and in a subgroup of 
AD patients, depression could have contributed to the development of the disease. This claim 
has had varying results (e.g., Geerlings, den Heijer, Koudstaal, Hofman, & Breteler, 2008), 
and it has been concluded with a history of depression being a risk factor for dementia (for 
review, see Jorm, 2001). This link has been proposed as being present because of prolonged 
exposure to glucocorticoids through a number of depressive episodes in the past could lead to 
hippocampal atrophy, and thereby lead to the development of AD (Jacobson & Sapolsky, 
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1991). Therefore, there are acceptable prospects for believing that both HCV and physical 
performance could be involved in patients’ experienced depressive symptoms. Although past 
depressive episodes are not screened for here, present depression is an important variable to 
look at in trying to better the patients’ overall well-being. 
H4: Physical performance will correlate positively with depressive symptoms, indicat-
ing that better physical performance is associated with lower levels of depression (high scores 
on the GDS). 
H5: There will be a positive association between HCV and GDS, i.e., greater HCV will 
be correlated with fewer depressive symptoms. 
Activities of Daily Living. Deficits in daily living skills have been associated with an 
increased use of healthcare, reduced quality of life and an increased distress for both the pa-
tient and the caregiver (Hope, Keene, Gedling, Fairburn, & Jacoby, 1998; Severson et al., 
1994; Vetter et al., 1999). Several observational studies have suggested that physical exercise 
on regular basis could be one of the most important factors preventing the onset of late-life 
daily living skills disability (Ferrucci et al., 1999; LaCroix, Guralnik, Berkman, Wallace, & 
Satterfield, 1993; Wu, Leu, & Li, 1999). Moreover, when examining the relationship between 
WM hyperintensity, HCV, and everyday functioning, Farias and colleagues (2004) found a 
significant correlation, but HCV was no longer significant when they controlled for age. 
An important goal in caring for AD patients is to help to maintain their ability to per-
form basic self-care activities such as dressing, bathing, eating without assistance, and trans-
ferring out of a chair or bed (Covinsky et al., 1998; Palmer, Landefeld, Kresevic, & Kowal, 
1994). To determine elderly individuals’ self-sufficiency and independence, Lawton and 
Brody (1969) developed the Self-Maintaining and Instrumental Activities of Daily Living as-
sessment (ADL). The questionnaire includes both practical ADLs (e.g., grooming, eating), 
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and instrumental ADLs (e.g., using the telephone, shopping). The performance on the various 
ADLs is dependent upon the integrity of numerous motor and cognitive systems. ALD im-
pairment often leads to early loss of independence and hence the capability of being an active 
and contributing member of society. In clinical AD patients, instrumental ADL (I-ADL) im-
pairment has been linked with global pathologic changes and posterior and frontal hypo-me-
tabolism (Marshall, Fairbanks, Tekin, Vinters, & Cummings, 2006; Rowe et al., 2007; Salmon 
et al., 2005). Nevertheless, exploring the field of hippocampal atrophy, physical performance 
and ADLs is an important area of research to help AD patients live independently at home for 
a longer period of time and increasing their quality of life. 
H6: There will be a negative correlation between ADL measures and HCV and SPPB, 
indicating that lower scores on the ADL (higher ability to perform daily activities) will be as-
sociated with greater HCV and better SPPB score. 
Objective and Overall Aim 
This thesis is a part of a larger project, but only covered a small portion of it. The 
ALMUTH project will look at music and exercise compared to a passive control group of 
people in an early stage of AD. The thesis serves as a pilot study for the ALMUTH study and 
one of the primary scientific goals will be to look at the AD patients’ HCV and whether 
greater HCV correlates with the patients motor performance. If AD patients with better physi-
cal performance show to have a greater HCV, this could be valuable information in future 
treatment plans. Whether cognition, depression, and the ability to perform daily activities is 
linked to physical performance and HCV will also be addressed. 
The objective of this study is to provide valuable information for the ALMUTH 
project in the form of pilot results to enable the research team to judge whether it is worth 
pursuing a full-scale investigation using HCV as a measure. By gaining knowledge on how 
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the brain of AD patients differ according to motor performance, it may change how we treat 
the disease in the future. In cooperation with Bergen Municipality, findings from the general 
study at large (the ALMUTH project) will be used to make good treatment plans for patients 
with AD in Bergen and Hordaland. 
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Methods 
Subjects 
Inclusion and exclusion criteria. To secure that the subject-pool in the pilot study 
consisted of patients who could see the entirety of the ALMUTH project through, several cle-
ar criteria were set. The predominant criteria were that the patients had to be diagnosed with 
early-stage AD, or be under evaluation for AD by their primary physician or by a senior con-
sultant, and the patients had to be able to give informed written consent. Patients were then 
included based on the following criteria: patient was above the age of 18; patient was in an 
early stage of the AD disease (lives at home/can give informed consent); patient does not have 
metal implants in body soft tissue for MRI purposes (pacemaker, stent); patient does not have 
hearing loss that cannot be corrected with hearing aid; patients had to live in or around the 
Bergen area to ensure their participation in possible intervention programs allocated through 
the study. All patients were living at home at the time of their first testing, albeit their age and 
physical activity variated. The current thesis is connected to IBMP at Haukeland, and a group 
under the Bergen fMRI group - the Brain and Music group, and the ALMUTH project. The 
data were thus collected at the university hospital Haukeland. The ALMUTH project has es-
timated a total of approximately 135 participants, but due to time limitation, the current thesis, 
and thereby the pilot study performed here, only looked at 12 subjects. Therefore, a total of 12 
participants were included in the analyses (mean age 74.8 ± 7.3, range: 59–83 years, female/
male (f/m) 7/8). Cognitive functioning was assessed by the Mini-Mental State Examination 
and depressive symptoms were screened for by the Geriatric Depression Scale. Daily func-
tioning was assessed using Activities of Daily Living, and physical performace was assessed 
using the Short Physical Performance Battery.  
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Recruitment. Patients were recruited from in and around the Bergen area through lo-
cal advertisement and public announcements. An appeal at Fyllingsdalen nursing home was 
made in front of the memory teams (HUK/hukommelsesteamene) from the Bergen area, who 
relayed the message to any patients and carers they believed to be interested in the research 
project. Several interviews with the local press were done, and flyers and posters were posted 
in places of interest. Appeals through social media were also carried out.  
Operationalization of Variables 
 The study looked at both neuroscientific, cognitive and physical measures. The main 
physical measure used in this study was the SPPB, which is described in detail in the proce-
dure section. The details and procedure of MMSE, GDS, and the two ADL measures that 
were used to answer hypothesis two, three, and four are described below. Baseline demo-
graphic data from each patient was be obtained, including sex, education level, age, medica-
tion usage, and any hearing deficits. HCV extracted with the FreeSurfer software is described 
later in the methods section. 
Depressive symptoms. Depression is very common in the elderly population, and the 
total score on the Geriatric Depression Scale (GDS) was used to identify depressive symp-
toms (see Appendix A). The measure was looked at specifically to identify any comorbid dis-
orders that might occur within the specific group of participants that are being tested. The test 
includes a set of 30 yes/no questions and was performed by a trained member of staff. The 
depression scale was developed by Yesavage and colleagues (1982), and a Norwegian version 
translated by Knut Engedal was utilized. 
Memory and attention. Patients with AD often suffers from attention and memory 
deficits early in the disease, and these deficits are some of the first symptoms to present. The 
Mini-Mental State Examination (MMSE) was developed in 1975 (Folstein et al., 1975), and a 
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three-times revised Norwegian version was used (Strobel & Engedal, 2016), see Appendix B. 
A total score of the MMSE provides an idea of the progression of the disease. The MMSE is 
used in a lot of AD research and can also be an indicator of the patient’s ability to learn and 
remember. The test has seven categories: orientation to time, orientation to place, immediate 
recall, mental arithmetic, delayed recall, language, and figure copying. The maximum score 
on the MMSE is 30 points, and any score above 27 is typical for normal cognitive function-
ing. A score of 20 to 24 usually suggest mild dementia or MCI, 13 to 20 suggests moderate 
dementia, and a score of less than 12 indicates severe dementia. On average, the MMSE score 
of AD patients declines approximately two to four points each year. The test was performed 
by a trained member of staff and lasted approximately 10 minutes.  
Daily living with Alzheimer. In order to determine how self-sufficient the participants 
are, the total score of the Instrumental Activities of Daily Living (I-ADL) and Physical Activi-
ties of Daily Living (P-ADL) was employed (see Appendix C). As this study had a focus on 
patients in the early stages of their disease, it was important to test the course of the illness, 
which can be indicated by their day-to-day activity level and how independent participants 
are. This was assessed via self-reported ability to independently perform activities of daily 
living in a scale developed by Lawton and Brody (1969). Eight I-ADLs included using the 
telephone, household, meal preparation, laundry, traveling beyond walking distance, shop-
ping, managing finances, and taking medications. Seven P-ADLs included bathing, grooming, 
eating, physical activity, using the bathroom, and getting dressed. Each question was scored 
on a scale from 0 to either 3, 4 or 5, with higher scores indicating a higher probability of the 
patient needing help in the different activities. A translated Norwegian version was used (Ap-
pendix C). 
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Physical performance. Patients were asked to perform the Short Physical Perfor-
mance Battery (SPPB), which is a set of objective measures of lower extremity physical per-
formance to determine their overall physical fitness level (see Appendix D). The test was de-
veloped by Guralnick and colleagues in 1994 (Guralnik et al., 1994) and a Norwegian version 
translated in 2013 was utilized here (Bergh, Selbæk, Strand, Taraldsen, & Thingstad, 2013). 
The procedure of the performance battery is described in detail below. 
Procedure 
Before recruitment and data collection started, the ALMUTH research project was 
admitted and approved by the Regional Committees for Medical and Health Research Ethics 
(REK, see Appendix E) and written informed consent (see Appendix F) was obtained from all 
participants according to the Declaration of Helsinki. The patients were taken to a room to 
complete all tests included in the ALMUTH test battery. Here, they completed the GDS, the 
MMSE, the I-ADL and P-ADL, and the SPPB. After the patients had completed the cognitive 
and physical screening, they were taken into an fMRI laboratory. They were asked some 
checklist questions before being guided to remove any metal they were wearing, and were 
debriefed on the procedure of the MRI machine. Patients were asked whether they had a mu-
sic preference for them to listen to inside the MR scanner and were given noise-canceling 
earplugs and a set of headphones with their desired music genre. The cognitive and physical 
screening lasted for approximately two hours, while the entirety of the MRI scan lasted for 30 
minutes. Thus, the total screening time lasted approximately 2,5 hours. 
Short Physical Performance Battery. All patients were asked to perform the SPPB 
as a part of the test battery. Here, patients went through the following tests; 1) balance tests, 2) 
gait speed test, and 3) chair stand test.  
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The balance tests (1) consisted of the following; a) a side-by-side stand, where patients 
were asked to stand with their feet together, side-by-side, for 10 seconds. Patients got 1 point 
for holding out 10 seconds, and 0 points for not attempting or not holding out the full 10 sec-
onds; b) a semi-tandem stand where patients were asked to put one foot in front of the other 
(optional order) with the side of the heel on the front foot touching the big toe on back foot. 
Here, the same scoring as for the side-by-side (a) test applied; the last balance test was a c) 
tandem stand, where they were asked to stand with the heel of one foot in front of and touch-
ing the toes of the other foot. Subjects got 0 points for holding the position for less than 3 
seconds, one point for holding 3 to 9.99 seconds, and two points for holding the position for 
the full 10 seconds. In all balance tests, patients were allowed to move their arms, move their 
body, or bend their knees in order to maintain balance, but were asked to keep their feet 
steady.  
In the gait speed test (2), the patients were asked to walk a three-meter long test course 
in their normal gait speed twice and was timed for each walk. If they needed to use a cane or 
other walking aid, they were allowed to. In both tests, the time of which it took the partici-
pants to walk the three meters was taken. The patients were scored in the following way; 1 
point if time was more than 6.52 seconds, 2 points if the time was between 4.66 to 6.52 sec-
onds, 3 points if time was between 3.62 to 4.65 seconds, and 4 points if time was less than 
3.62 seconds. 
Lastly, patients were asked to do chair stand tests (3). In the first part, patients were 
asked if they thought they could safely to try to stand up from a chair without using their 
arms, and if yes, they were asked to do so with their arms with their hands folded across their 
chest. If the patients were able to perform the task, they were asked if they thought they were 
able to do five repetitive chair stands. If yes, the scoring was as follows; 0 points if partici-
HIPPOCAMPUS, PHYSICAL PERFORMANCE AND ALZHEIMER’S DISEASE                                   !36
pants were unable to complete five chair stands or used more than 60 seconds, 1 point if chair 
stand time was 16.70 seconds or more, 2 points if the time was 13.70 to 16.69 seconds, 3 
points if chair stand time was 11.20 to 13.69 seconds, and 4 points if the patient spent 11.19 
seconds or less when doing five chair stands. 
Experimental Design.  
For the pilot study, the HCV of the patients was the dependent variable. There were 
several independent variables, the main variable being the patients physical performance. As 
described above, several physical and cognitive measures were collected to help answer the 
hypotheses: the SPPB was performed to measure the patients motor performance and level of 
fitness, the MMSE was performed to measure the patients’ mental state (memory and atten-
tion); the GDS was performed to measure patients’ depressive symptoms; the ADL tests were 
performed to measure patients activities of daily living (practical and instrumental). Patients 
HCV and TIV were extracted from MRI scans. All participants took part in the entirety of the 
experiment and was measured once. 
MRI Acquisition and Pre-Processing 
 A 3.0 Tesla MRI machine (General Electric MRI machine) at the MRI department of 
the Haukeland University Hospital in Bergen was used to obtain all participants MRI data, 
with a 32-channel phased-array head coil. For each subject, 3D T1-weighed, high-resolution 
anatomical images were acquired using a magnetization-prepared rapid acquisition gradient 
echo (MP-RAGE) sequence with the following acquisition parameters: echo time (TE) of 30 
ms, repetition time (TR) of 2250 ms, with a nominal voxel size of 1x1x1 mm. All participants 
wore MRI compatible glasses (with either corrective or non-corrective lenses) and was given 
NNL headphones for presenting music stimuli with high sound quality.  
HIPPOCAMPUS, PHYSICAL PERFORMANCE AND ALZHEIMER’S DISEASE                                   !37
 Additional image corrections were applied to the T1 images, using the following pro-
cessing pipeline: (1) data were organized according to the Brain Imaging Data Structure 
(https://bids.neuroimaging.io), (2) Ditcom data were converted into NIfTI format using 
dcm2niix, distributed with MRIcroGL (https://www.nitrc.org/projects/mricrogl), (3) anatomi-
cal data were defaced using mri_deface, distributed with FreeSurfer (https://surfer.nm-
r.mgh.harvard.edu/), (4) HCV and total intracranial volume (TIV) were estimated using re-
con-all (from FreeSurfer) with default parameters, and (5) bilateral average HCV was normal-
ized by TIV for each participant.  
Hippocampal Volume Estimation 
 All participant scans were processed using FreeSurfer version 5.3.0 (Dale, Fischl, & 
Sereno, 1999; Fischl et al., 2002; Fischl, 2012) (freely available online at http://surfer.nmr.m-
gh.harvard.edu/), using a MacBook Pro with OS X 10.10.5, processor 2.5 GHz Intel Core i7 
processor, with a 16 GB 1600 MHz DDR3 RAM. FreeSurfer is a tool providing quantitative 
volume data for a range of brain structures, including the hippocampus. FreeSurfer uses a 
technique that estimates the probability of each voxel on an MR image to belong to a given 
structure based on a-priori knowledge of spatial relationships acquired with a training set. The 
software segments the hippocampus based on these neuroanatomical labels to each voxel. The 
exact methods of the automated volumetric approach have been described in detail previously 
(Fischl et al., 2002). A fully automated procedure was utilized using the FreeSurfer recon-all 
pipeline, which performs all of the FreeSurfer cortical reconstruction processes. The 
following major steps are performed by FreeSurfer’s recon-all function: intensity normaliza-
tion, motion correction, skull stripping, removal of non-brain tissue, brain mask generation, 
cortical reconstruction, WM, and subcortical segmentation, cortical tessellation generating 
GM-WM and GM-pia interface surface triangulations, and probabilistic atlas based on corti-
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cal and subcortical parcellation. The analysis was restricted to the right and left hippocampus, 
and the total intracranial volume (TIV), respectively, for the purpose of this thesis.  
 Right and left HCV and TIV were extracted for analysis in SPSS. To control for indi-
vidual differences in head size, the main HCV used was expressed as a TIV ratio (left+right 
hippocampus/TIV). 
Ethical Concerns  
Patients with AD are already an exposed group, even at an early stage of their disease. 
The current thesis was a part of an intervention study using participants living at home, and as 
a result of the intervention from the ALMUTH project could hopefully live at home longer. To 
this day, there are few high-quality studies investigating how long-term musical and exercise 
therapy can benefit AD patients. The pilot data from this study, and consequently the AL-
MUTH project has great potential for benefiting patients, and through the therapy that will be 
implemented in Bergen Municipality from the recommendations ALMUTH study. 
Being in an MRI machine may be experienced as uncomfortable or claustrophobic for 
some of the participants. An MRI scan is not dangerous, and it was necessary for the current 
research project. To limit the discomfort, however, several measures were taken; participants 
got to see nice nature pictures whilst inside the scanner and listened to the music of their 
choosing from one of six different genres. Moreover, some of the physical and cognitive tests 
may also be considered uncomfortable as they ask about sensitive information. Participants 
ID was masked by using an ID number rather than the name of the participant. The only doc-
uments with their full name were the informed consent form (Appendix F). The papers were 
locked up at the IBMP in the office of the project leader, Stefan Koelsch. Only the members 
of the Brain and Music group had access to project leader office.  
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The hope of the ALMUTH project is to help the patients stay and live independently at 
home longer. Whether they are assigned to the exercise group or the music group, the hope is 
that the intervention they receive will contribute to cognitive stimulation and a better quality 
of life. The current thesis only used data for those who are intended for the ALMUTH project, 
which will hopefully show beneficial results for the participants. A control group will not be 
applicable for the current thesis but will be for the ALMUTH project. The patient’s score on 
the SPPB or patient’s HCV will not effect which intervention group that they will be random-
ly assigned to. Participants were not economically compensated for their participation, but 
they might be in one of the two intervention groups and receive 12 months of free therapy in 
the form of music therapy or physical exercise. The project is funded by the NRF and has 
been approved by the REK committee (Appendix E). They will not be allowed to participate 
in the study unless they are able to give informed consent for their participation. As the REK 
committee has redeemed the ALMUTH project as health research, submitting the project 
through Personvernombudet for Forskning (NDS) was not necessary. 
Statistical Analysis 
 All Spearman’s rank correlation coefficients were performed using the statistical soft-
ware IBM SPSS for Mac (version 25, www.spss.com). A correlation between SPPB and all 
HCV measures were performed to investigate the main research question on the relationship 
between HCV and physical performance. To answer the second hypothesis, correlations be-
tween all hippocampal measures and MMSE was performed, and a correlation between 
MMSE and SPPB was performed to examine the third hypothesis. For the fourth hypothesis, 
a Spearman’s correlation was calculated between GDS and all HCV measures. The fifth hy-
pothesis was answered by performing a correlation between SPPB and GDS. For the sixth and 
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final hypothesis, a correlation between I-ADL, P-ADL, all hippocampal measures, and SPPB 
was performed. 
 The Spearman’s Rank Correlation Coefficient (Spearman’s Rank-Order Correlation or 
Spearman’s rho) is a nonparametric measure of rank correlation. It differs from Pearson’s cor-
relation in that it looks at the monotonic relationship between two variables instead of assess-
ing the linear relationship. There are several benefits to using Spearman’s rho, in that its non-
parametric technique is unaffected by the population distribution, and it is relatively insensi-
tive to outliers. The disadvantage of using this non-parametric technique is that there can be a 
loss of information when the raw data is converted to ranks. 
 Spearman’s rank correlation was utilized as the main analysis for significance between 
all variables in this thesis. Essentially, the Spearman rank correlation test is the nonparametric 
version of the Pearson correlation coefficient. Usually, Spearman’s rho is used when either 
one or both variables are ranked but can be employed instead of linear regression/correlation 
if there is a question about the normality of the distribution. When testing the sample for nor-
mality using the one sample Kolmogorov-Smirnov test, most variables did not satisfy the 
normality assumption (I-ADL, P-ADL, GDS, SPPB, left hippocampus, gender & TIV). This 
was most likely due to the small sample of participants. The MMSE, right hippocampus, total 
HCV, TIV-adjusted TIV, and age were normally distributed. In their paper on sample size re-
quirements for estimating Pearson, Kendall, and Spearman correlations, Bonnet and Wright 
(2000) suggested that Pearson correlations should only be utilized if n >25, and if the assump-
tion of bivariate normality cannot be justified, then Spearman correlation should be consid-
ered. If the data is normally distributed, a Pearson correlation could be more powerful. How-
ever, because of the issue of normality and the small sample of the thesis, the Spearman’s rho 
was used. 
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Results 
Due to the thesis serving as a pilot study, the following results can be seen as a proof-
of-concept, meaning that the results found here are only meant to demonstrate the feasibility 
of the method used in the current thesis, and may have practical potential for the ALMUTH 
project.  
The total sample included 12 participants, where seven were male (58.3%). All participants 
were right-handed and had finished primary school. Five participants had obtained a Bache-
lor’s Degree or higher. Descriptive statistics and mean scores and measures can be found in 
Table 1. A Spearman’s Rank two-way correlation was performed to assess the non-parametric 
relationship for all variables (see Table 2).  
Table 1




Short Physical Performance Battery 9.50 (3.12)
Mini-Mental State Examination 21.67 (3.09)
Instrumental Activities of Daily Living 15.08 (7.20)
Practical Activities of Daily Living 7.42 (1.93)
Geriatric Depression Scale 7.17 (4.84)
Hippocampal Volume Adjusted by Total Intracranial Volume 0.004151 (0.00102)
Left Hippocampal Volume, cm3 3.143 (0.897)
Right Hippocampal Volume, cm3 3.160 (0.829)
Total Hippocampal Volume, cm3 6.303 (1.597)
Total Intracranial Volume, cm3 1518.169 (114.811)
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Hippocampal Volume 
Generally, the hippocampal measures show good agreement. Total HCV volume and 
TIV-adjusted HCV had a very strong, positive correlation rs(10) =.944, p<.001. The total 
HCV and both the left side, rs(10) =.895, p<.001, and the right side of the hippocampus rs(10) 
=.825, p<.001 showed a strong positive significant correlation. The left and right hippocam-
Table 2
Correlation Matrix for age, physical- and cognitive measures, and hippocampal volume estimations
1 2 3 4 5 6 7 8 9 10 11 12
1. Hippocampal 
volume adjusted 














.944** .895** .825** 1
5. Total Intracranial 
Volume
-.014 -.021 .462 .252 1
6. Instrumental 
Activities of Daily 
Living 
.098 .014 .155 .053 .151 1
7. Practical 
Activities of Daily 
Living
-.241 -.030 -.245 -.260 .030 .526 1
8. Geriatric 
Depression Scale
.685* .638* .506 .613* -.115 .418 .052 1
9. Mini-Mental 
State Examination
.570 .553 .148 .419 -.563 -.246 -.025 .413 1
10. Short Physical 
Performance 
Battery
.359 .241 .237 .334 -.119 -.580* -.798** .258 .251 1
11. Age -.099 -.276 -.007 -.149 .103 -.125 -.072 -.361 .100 -.064 1
12. Gender -.073 .024 -.426 -.220 -.759** .025 -.053 .402 .247 .201 -.496 1
Note: ∗p < .05. ∗∗p < .01. 
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pus had a moderate positive significant correlation rs(10) =.580, p=.048. TIV-adjusted HCV 
had a strong, positive correlation with the right hippocampus rs(10) =.769, p=.003, and the left 
hippocampus rs(10) =.888, p<0.001. 
Physical Performance and Hippocampal Volume 
The relationship between TIV-adjusted HCV and SPPB scores was found to be moder-
ately positive but non-significant, rs(10) =.359, p=.252. The correlation for SPPB and left hip-
pocampus was weakly positive for both the left, rs(10) =.241, p=.451, and for the right, rs(10) 
=.237, p=.458. The correlation between SPPB and total HCV was positive and moderate at 
rs(10) =.334, p=.289. Generally, there were positive but non-significant, trends for SPPB and 
all HCV measures. 
Cognition 
A moderate positive relationship was found for TIV-adjusted HCV and MMSE, 
rs(10)=.570, p=.053. Similar results were found for the relationship between MMSE and the 
left hippocampus with a moderate, but non-significant correlation, rs(10) =.553, p=.062, and 
the total HCV, rs(10) =.419, p=.175. The relationship between MMSE and the right hip-
pocampus was positive, although the correlation coefficient was very weak, rs(10) =.148, p=.
646. These results are approaching significance, and could generally indicate that a larger 
hippocampus is associated with a better ability to learn and remember. The relationship be-
tween SPPB and MMSE showed a non-significant, weak positive correlation coefficient, 
rs(10) =.251, p=.431. 
Depression 
The association between TIV-adjusted HCV and GDS was found to be a strong posi-
tive relationship, rs(10)= .685, p= .014. The relationship between GDS and the left hippocam-
pus was strong and positive, rs(10) =.638, p=.26, and for GDS and the right hippocampus the 
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association was moderate and not significant, rs(10) =.506, p=.094, leaving the correlation for 
GDS and total HCV at a strong positive and significant result, rs(10) =.613, p=.034. General-
ly, these results indicate a high probability of patients’ depression symptoms is affected by or 
effects HCV. There was no significant relationship between GDS and SPPB rs(10) =.258, p=.
481.  
Daily functioning 
There were two measures indicating the self-sufficiency and daily functioning of the 
patients, namely the I-ADL and P-ADL. The relationship between SPPB and both the ADLs 
yielded significant results. For the relationship between P-ADL and SPPB there was a strong 
negative correlation rs(10) =-.798, p=.002. There was a moderate negative correlation for 
SPPB and I-ADL, rs(10) =.580, p=.048. Higher scores in I-ADL and P-ADL indicate a lower 
level of self-sufficiency and -independency, and higher scores in SPPB indicate better physi-
cal performance. These results, therefore, suggest that patients who have better physical per-
formance have a tendency to be more independent and self-sufficient. 
There was found no apparent relationships between any hippocampal measures and 
the ADLs. For P-ADL, the association with TIV-adjusted HCV was negative and weak rs(10) 
=-.241, p=.451, and for I-ADL there was no relationship with TIV-adjusted HCV, rs(10) =.
098, p=.761. 
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Discussion 
The present study set out to explore the relationship between HCV and physical per-
formance in AD patients at an early stage of their disease. The aim was to provide valuable 
pilot data for the ALMUTH project to evaluate whether to spend time and resources on in-
vestigating the relationship between hippocampal atrophy and motor performance further at a 
greater scale. Implications from the literature could suggest that high scores on the SPPB 
could be associated with greater HCV. The study failed to find any significant relationship 
between either measures, albeit the correlations showed positive trends. The ALMUTH study 
will use both healthy controls and a larger sample. Therefore, because the relationship betwe-
en HCV and SPPB was moderate, these pilot data suggest that there is a possibility for a sig-
nificant association to be seen in the longitudinal interventional study ALMUTH will carry 
out. 
Physical Performance 
The data suggest a moderate, and non-significant relationship between SPPB and TIV-
adjusted HCV, which could indicate that when the patients’ motor performance is better, the 
HCV would be equally great to some extent. Although the relationship was non-significant, it 
had a positive direction and demonstrates a proof-of-concept, meaning that if the participant 
number were higher, it might have yielded a stronger result. The correlations between SPPB 
and the right and left hippocampus was weak, but the total HCV showed a moderate correla-
tion. Nevertheless, TIV-adjusted HCV is the most important measure to look at as it takes par-
ticipant head size into account and adjusts for it with regard to HCV. These results are confir-
ming the main hypothesis to a certain extent and as pilot data, they provide valuable informa-
tion in the future of the ALMUTH project. Seeing these moderate, positive results with a very 
small sample, could yield significant results in the future with larger data sets. The ALMUTH 
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project cooperates with Bergen Municipality in finding good treatment plans for AD patients 
in and around the Bergen area. If the ALMUTH group find these data encouraging and choo-
ses to go forward with these promising results, then the project could provide valuable insight 
into which treatment plans to follow in the primary care of AD patients.  
The SPPB is a standardized measure of lower extremity physical performance that in-
cludes balance, walking, and strength tasks. The main outcome of the ALMUTH project is to 
help AD patients stay at home longer after they have received an AD diagnosis. Low scores of 
the SPPB has been associated with clinically relevant outcomes that are independent of other 
socioeconomic factors and health conditions, a claim that have been confirmed across diver-
gent populations and settings (Guralnik et al., 2000; Guralnik et al., 1995; Guralnik et al., 
1994; Onder et al., 2005; Ostir, Markides, Black, & Goodwin, 1998; Penninx et al., 2000; 
Rolland et al., 2006). The loss of independence is a major concern when considering how to 
help AD patients live at home. It is evident that low scores on the SPPB can cause this loss of 
independence to occur much earlier than necessary. Therefore, it is interesting to see whether 
SPPB scores and thus independence, can be improved through physical activity intervention 
that the ALMUTH study will provide. A study looking at over 400 sedentary persons at risk 
for disability in the age-range 70 to 89 years did a randomized controlled trial to investigate 
the effects of physical activity interventions on measures of physical performance (LIFE 
Study Investigators*, 2006). Here, subjects were allocated to either a moderate-intensity phy-
sical activity intervention or to a successful aging health education intervention and were 
followed for an average of 1.2 years. The researchers found that a structured physical activity 
intervention improved the SPPB performance and other measures of physical performance 
and that such intervention improving SPPB scores may offer benefit on more distal health 
outcomes, such as mobility impairment. Their physical activity intervention consisted of a 
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combination of balance, strength, aerobic, and flexibility exercises, and a full overview can be 
found in their article. Although it does not seem as though a similar study has been performed 
on AD patients, these results are very promising. The ALMUTH project will, similarly, do a 
randomized controlled trial where one group will receive song intervention, one group will 
serve as controls, and the last group will receive physical activity intervention. If the results 
from the physical activity group yield similar outcomes as reported earlier in the literature, it 
will become very useful in helping caregivers and physicians to administer alternative, non-
pharmacological approaches to treating dementia. Moreover, if the ALMUTH study chooses 
to go forward with these data, and HCV and SPPB scores still show a moderate relationship, 
there is a possibility hippocampal atrophy slowing down for the patients included in the study. 
Validity and reliability of the SPPB have been confirmed across several populations 
and age-groups as mentioned earlier in this thesis. A Finnish intervention study (Pitkälä et al., 
2013) did, however, find that the SPPB was found difficult to conduct on AD patients. They 
found that instructing dementia patients to perform the test correctly proved difficult. While 
the paper does not comment on the progression of the AD in their participants, patients had to 
be on the AD drug reimbursement register of the Social Insurance Institution of Finland, sug-
gesting they could be further along in their disease progression than patients included here. As 
patients in the current study were in an early stage of their disease and did not express confu-
sion around the various SPPB tasks, it was concluded that patients found the SPPB instruc-
tions manageable.  
The SPPB has been considered a good measure of not only present physical perfor-
mance but also for representing how physically active subjects are on a general basis. Benefi-
cial effects of physical activity on cognitive functioning has been demonstrated recurrently, 
albeit most research is derived from animal models (Erickson & Kramer, 2009; Fillit et al., 
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2002; Kramer et al., 2006). Cardiovascular health and glucoregulation can be part of increas-
ing the risk of AD when compromised (Craft, 2005; Gasparini & Xu, 2003; Helzner et al., 
2009; Kuusisto et al., 1997), and exercise has been shown to have positive effects on these 
processes. Furthermore, the presence of midlife cardiovascular risk factors such as high cho-
lesterol, obesity, hypertension, and smoking could substantially increase the risk of late-life 
dementia (e.g., Whitmer et al., 2005b). Physical activity has shown to improve or entirely re-
move some of these risk factors, and it can be assumed that a healthy and active lifestyle 
throughout the course of one’s life could generally lessen the risk of developing dementia all-
together, but this would need a large-scale longitudinal study to scrutinize. Nonetheless, HCV 
and physical performance do seem to have an association, and it will be of common neu-
ropsychological interest to see the findings of the ALMUTH study to further the results ob-
tained here. 
Cognition 
The study demonstrated a positive association between MMSE and TIV-adjusted 
HCV. Although the relationship, amongst other hippocampal measures, was not significant, 
the relationship was moderate, and very close to significance at the p<.05 level. With this, H2 
is confirmed with reservation. The relationship between SPPB and MMSE showed a non-sig-
nificant, weak positive correlation coefficient, indicating that there could be a small associa-
tion between the patients’ memory and attention, and their physical abilities. The correlation 
shows a positive trend but would need further attention with a larger sample for any conclusi-
ve judgements. Therefore, for the current thesis, the third hypothesis is disconfirmed. 
 In primary care, screening for dementia and memory deficits often relies on cognitive 
screening tests, such as the MMSE, and persons with multimodal functional deficits, such as 
AD, typically score less than 24. The mean MMSE score in the sample in this study was at 
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21.7, which is an indication of MCI. Typically, for persons in the preclinical stages of AD, 
MMSE scores are less sensitive and scores tend to fall within the normal range (≥ 24) 
(Pasqualetti et al., 2002). Pasqualetti and colleagues conclude in their study that traditional 
MMSE cutoff values should be approached with warning, as they may not be appropriate in 
detecting early dementia. Looking at the MMSE scores, patients were in an early stage of the 
disease, and most patients had an MMSE score of 24 or below. It could be argued that the lack 
of significance in the relationship between HCV and MMSE is due to patients’ AD not having 
progressed enough to see greater hippocampal atrophy. Nonetheless, it is well-established that 
early pathological changes, especially in the MTL and hippocampus, often occurs years be-
fore clinical symptoms of AD present. HCV has consistently shown to be reduced by up to 
40% in patients who have been clinically diagnosed with a moderate severity of AD (Jack, 
Petersen, O'brien, & Tangalos, 1992; Kesslak et al., 1991; Seab et al., 1988). Moreover, the 
extent to which the hippocampus atrophies have been shown to correlate with memory im-
pairment and overall severity (Deweer et al., 1995; Kesslak et al., 1991; Laakso et al., 1995). 
Patients with similar MMSE scores to our sample at >21 have shown to already have lost 
about 25% at this stage of AD when compared to healthy controls (Killiany et al., 1993; Lehe-
ricy et al., 1994; Laakso et al., 1995).  
General cognition has been seen in many studies worldwide to correlate with inc-
reased physical activity and performance (for a review, see Hillman, Erickson, & Kramer, 
2008). SPPB measures strongly correlate with present physical activity level, and seeing a 
link between MMSE and SPPB is therefore to be expected. This study did not have healthy 
controls for comparison, albeit the ALMUTH project will. Hence, it is to be expected that 
both with the large sample size, and healthy controls for comparison, the results will yield 
more significant relationships between MMSE, SPPB and HCV. 
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Depression 
There was found a strong, significant relationship for depressive scores and hippo-
campal measures. The right hippocampus did not have a significant relationship with GDS but 
was moderate and positive. The left hippocampus and the total hippocampus had a significant 
association with depressive symptoms, and the correlation was stronger when TIV was 
accounted for. The fourth hypothesis is thereby confirmed. These findings are along the lines 
of previous research into HCV of depressed subjects. It has been hypothesized that a history 
of depression, and by prolonged exposure to glucocorticoids through several depressive epi-
sodes, could lead to hippocampal atrophy and subsequently lead to the development of AD 
(Jacobson & Sapolsky, 1991). This study did not screen for previous depressive episodes and 
whether patients displaying depressive symptoms at the time of the screening have a history 
of depression is therefore difficult to account for. However, seeing such a strong association 
between current depressive symptoms and HCV in a pilot study is compelling.  
There was no significant relationship between GDS and SPPB, disconfirming the fifth 
hypothesis. There are varying results on physical activity and depression in the literature. In a 
meta-analysis Craft and Landers (1998) reported a relatively large effect size (d︎︎=0.72) when 
looking at the effect of exercise on clinically depressed individuals. Little research has been 
conducted on AD patients, depression, and physical performance, but as mentioned in the in-
troduction, Williams and Tappen (2008) found that AD patients had a clear benefit of exercise 
as a behavioral approach to treat depression. This thesis did not look at exercise intervention 
such as Williams and Tappen did, and little research has looked at specifically physical per-
formance and depression in AD patients. It is therefore difficult to draw any conclusions 
based on previous literature. Nonetheless, the results from this thesis did not yield any signifi-
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cant results, but the ALMUTH project utilizing intervention similar to Williams and Tappen 
might find more positive results. 
One paper has concluded that the GDS is not adequate for detecting depression in AD 
patients, and found a marked decrease of internal consistency in the AD group (Müller-Thom-
sen, Arlt, Mann, Maß, & Ganzer, 2005). These patients were in later stages of AD, and other 
research has suggested that cognitive decline can affect the results of the GDS (Zarb, 1996). 
In the current study, patients had a mean MMSE score of 21.7, indicating a mild cognitive 
impairment, so it should be assumed that the internal consistency is adequate. On average, 
after being diagnosed with AD, patients’ MMSE score worsens by two to four points each 
year. It seems like there is no need for concern with patients in the early stages of the disease, 
but a longitudinal study such as the ALMUTH study should, therefore, investigate whether 
the GDS is the best measure for screening depression in their group of patients. 
Activities of Daily Living 
Looking at the results, it seems as though HCV does not play a part in patients ability 
to perform ADLs. There is little research in this field, but some studies have found an associa-
tion between instrumental ADLs and brain volume. The results from the current study yielded 
a significant relationship for neither P-ADL nor I-ADL with HCV, which again could be due 
to a number of reasons. When Farias and colleagues (2004) examined the relationship betwe-
en HCV and ADL, the association was significant, but when controlling for age, the correla-
tion disappeared. Another study used a community-dwelling population to investigate whether 
structural and microstructural brain changes were associated with ADLs, and found that smal-
ler brain, HCV and higher diffusivity were associated with changes in ADLs (Verlinden et al., 
2014). Nevertheless, their study did not do follow-up MRIs, making it difficult to establish 
whether changes in brain pathology coincided with a change in ADLs. The population was 
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also relatively healthy, not affected by AD, so it is impossible to say whether their findings 
can be generalized to an AD population. Moreover, the relationship between neuropsycholog-
ical test performance and ADL in elderly psychiatric patients has shown to be moderate (Nad-
ler, Richardson, Malloy, Marran, & Brinson, 1993; Richardson, Nadler, & Malloy, 1995). 
Thus, the lack of association between HCV and ADL is not surprising and in line with pre-
vious research. Although it was not a focus for the analysis, worth mentioning is the rela-
tionship between I-ADL and GDS. From looking at Table 2, there is a moderate, although 
non-significant relationship between the two. It is interesting that P-ADL has no association 
with GDS, but not being able to perform activities such as doing one’s own shopping and 
using the phone (I-ADL activities) can play a role in these patients quality of life. 
There was found a strong relationship between P-ADL and SPPB, and a moderate re-
lationship between I-ADL and SPPB. This is most likely due to patients who score high on 
the SPPB does have better physical performance, making it easier to perform activities such 
as shopping and bathing. Where patients are not able to, for example, walk five meters wit-
hout help, it is likely that they will struggle to perform daily activities without help from a 
caregiver. The P-ADLs are very personal, physical activities such as getting dressed and using 
the toilet. Such activities correlate closely with the physical abilities tested by the SPPB, and a 
strong correlation here is to be expected if the AD patients are able to correctly self-report in 
the ADL. Therefore, the sixth hypothesis is somewhat confirmed in that it appears easier for 
patients to perform daily activities if they score higher on the SPPB, but HCV does not seem 
to be involved in daily functioning. 
 Guralnik and colleagues (1994) reported that physical performance and self-reported 
disability was strongly associated, and were both independent predictors of nursing home ad-
mission and short-term mortality. Liu and Latham (2009) found that elderly exercising muscle 
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strength, and thereby increasing their physical performance, achieve better function in daily 
activities. Therefore, these findings on SPPB and ADL are along the lines of previous rese-
arch linking physical performance and daily functioning. 
Hippocampal Volume 
In the present study, an automated approach by FreeSurfer (Dale et al., 1999; Fischl et 
al., 2002; Fischl, 2012) was used to determine HCV. The results show good agreement across 
the different hippocampal measures, indicating that the measures are consistent across the 
participants. Looking through the literature, the HCVs of the participants of this study is 
slightly larger than usual. The mean HCV for the patients in the present study was measured 
to 6.303 cm3, which is larger than what one would expect in AD patients. A study by Tae and 
colleagues (2008) validating HCV measures in patients with chronic major depressive disor-
der and controls found that when using the Freesurfer automated hippocampal volumetric 
method, HCV was 35% larger. This was thus to be expected, and although not desirable, due 
to time limitations it was necessary to utilize an automated approach, and not the «gold stan-
dard» manual segmentation. In an article from 2014, a group of quantitative researchers 
looked at the differences in HCV change and the reproducibility of two automated approaches 
(FreeSurfer and FIRST) and expert manual outlining (Mulder et al., 2014). They found that 
quantitative reproducibility values of 1-year microliter and percentage HCV change were 
about the same for all three approaches, but that the FreeSurfer reproducibility was statistical-
ly significantly superior to both FIRST and manual outlining after exclusion of failed segmen-
tations. Consequently, using FreeSurfer with the recon-all function for the current thesis is 
well-founded.  
Due to time limitations, it was not possible to look at the hippocampal volumetric 
changes over time. This will be done in the ALMUTH project, independent of the outcomes 
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of this thesis, which can offer valuable information when taking the different intervention 
programs into account.  If the patients in the current study do show hippocampal atrophy dif-
ferentiation from that of healthy age-matched controls, it could be due to BDNF. In AD pa-
tients, there is a loss of BDNF of the hippocampus (Connor et al., 1997; Hock et al., 2000; 
Narisawa-Saito et al., 1996). Because BDNF is believed to contribute in the loss of neuronal 
tissue, it can be assumed due to it being anterogradely trafficked into the hippocampus by the 
entorhinal cortex (Yan et al., 1997), it may play a big role in hippocampal atrophy. Recently, 
research has looked into how exercise can contribute to increasing the level of BDNF in the 
hippocampus (for review see Cotman et al., 2007). Although this is a very interesting area of 
research, it would need a different methodology on a cellular level to investigate further. Nev-
ertheless, if it is so that exercise can slow down hippocampal atrophy, the various underlying 
processes should be considered. 
It was not feasible to utilize the BrainAGE paradigm developed by Franke and col-
leagues (2010) for this thesis, but it will be included for the ALMUTH project. It has been 
claimed that if the estimated BrainAGE is higher than a patient’s chronological age, a positive 
BrainAGE score indicates accelerated atrophy, which is considered a risk factor for conver-
sion to AD. The BrainAGE framework’s ability to correctly identify persons with MCI who 
will convert to AD has been compared to biomarkers from cerebrospinal fluid (CSF), cogni-
tive scales, and to HCV (Gaser et al., 2013). It was found that BrainAGE outperformed all 
cognitive measures as well as CSF biomarkers. Interestingly, even though HCV has previous-
ly shown to represent an independent risk factor for AD and in predicting MCI conversions to 
AD (Apostolova et al., 2006b; Devanand et al., 2007), the BrainAGE approach outperformed 
this prediction utilizing baseline HCVs in other recently published classification studies 
(Costafreda et al., 2011; Risacher et al., 2009; Risacher et al., 2010). Although for the purpose 
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of this thesis, it was not necessary to look at conversion from MCI to AD, it would be inter-
esting to look at the patients of this thesis’ BrainAGE as it helps differentiate a pattern of 
brain atrophy that deviates from that of a normal, healthy brain.  
It is crucial to address that although the evidence for hippocampal atrophy in AD is 
compelling, it may lack both specificity and sensitivity at the MCI stage, as it can present in 
other, non-AD forms of dementia, such as frontotemporal lobar degeneration (van de Pol et 
al., 2006), semantic dementia (Chan et al., 2001), and vascular dementia (Bastos-Leite et al., 
2007; Laakso et al., 1996).  Our patients had, however, been diagnosed with AD by their pri-
mary physician or by an attending physician. Although looking at the MMSE scores, patients 
were mildly cognitively impaired, it could also mean they were in an early stage of their dise-
ase. Withal, it is difficult to draw any conclusions from such a small sample as has been used 
in this thesis. 
The hippocampus consists of several subfields and recognizing the differentiated pat-
terns of atrophy in AD is important. Studies looking at hippocampal subfields through the use 
of MRI scans found a consistent alteration in the subfield CA1 of the hippocampus, both for 
volumetric (Boutet et al., 2014; de Flores et al., 2015; Iglesias et al., 2015; La Joie et al., 
2013; Mueller & Weiner, 2009; Wisse et al., 2014b) and surface-based methods (Apostolova 
et al., 2006a; Apostolova et al., 2012; Chételat et al., 2008; Frisoni et al., 2006; Frisoni et al., 
2008; Gerardin et al., 2009; Mak et al., 2016; Tepest et al., 2008; Wang et al., 2006). When 
comparing healthy controls to MCI patients, CA1 had the most consistent shape alteration 
(Apostolova et al., 2012; Chételat et al., 2008; Gerardin et al., 2009; Tang et al., 2015; Tepest 
et al., 2008) or volume reduction (La Joie et al., 2013; Pluta, Yushkevich, Das, & Wolk, 2012; 
Yushkevich et al., 2015). Moreover, MCI patients who converted to AD showed greater CA1 
and subiculum atrophy than of those who did not convert (Apostolova et al., 2006a; Chételat 
HIPPOCAMPUS, PHYSICAL PERFORMANCE AND ALZHEIMER’S DISEASE                                   !56
et al., 2008) with similar results for healthy controls converting to AD (Apostolova et al., 
2010; Csernansky et al., 2005). The FreeSurfer software has received various criticisms with 
regard to hippocampal subfield segmentation (Wisse, Biessels, & Geerlings, 2014a). In their 
critical appraisal, Wisse and colleagues conclude that the boundaries of the parcellation sche-
me of FreeSurfer version 5.3.0 (as used for this thesis) are in a mismatch with known anato-
mical boundaries, impacting the reliability of subfield atrophy in neuropsychiatric diseases. 
Therefore, recognizing these criticisms, if the current study were to look at the subfields of 
the hippocampus, it would be necessary to employ a different segmentation methodology. As 
mentioned previously, the validity of FreeSurfer has been confirmed numerous times concer-
ning total HCV segmentation, and it is accordingly of no concern utilizing the software for the 
purpose of total HCV. 
Limitations 
The ALMUTH project was in the beginning phase of testing participants for their in-
tervention study, leaving this study with a sample of 12 participants. Due to the study being 
connected to the ALMUTH study, being a longitudinal intervention study, recruiting partici-
pants was found to be difficult. All participants had to have been diagnosed with AD, and they 
needed to make their way to Haukeland University Hospital in a time-slot appropriate for 
both the participant, their caregiver, and for the MR department at the Haukeland University 
Hospital. This, alongside with other predicaments, made it difficult to start the project at the 
planned time. The current thesis had already been postponed 6 months waiting for more par-
ticipants to sign up for the study, and it was thus determined to go forward with the 12 partic-
ipants and wait no longer. Nevertheless, the study only serves as a pilot study for the AL-
MUTH project, allowing a sample of 12 participants, and its promising results will serve as 
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good predicaments for future research. The small sample size will, therefore, serve as a good 
future benchmark for the ALMUTH study. 
Alzheimer’s disease patients is a very vulnerable group, and understanding a variety of 
questions and tasks in a small amount of time can be difficult. The testing session with physi-
cal and cognitive measures lasted for an entirety of approximately two hours before patients 
were taken to the MR machine for scanning for another 30-45 minutes. This is a lengthy 
process for any individual, let alone an AD patient. The GDS is a well-established measure 
for depression in geriatric patients. With the long set of tests our patients were asked to per-
form, it could be useful to utilize the GDS questionnaire with only 15 questions, as opposed 
to the 30-question scale our patients performed. Its validity has been confirmed across several 
populations (e.g., Conradsson et al., 2013; Durmaz, Soysal, Ellidokuz, & Isik, 2018; Foun-
toulakis et al., 1999), and it could be useful utilizing the GDS-15 to shorten the time spent on 
the test battery. All patients were allowed to take breaks when desired and had a primary 
caregiver in the neighboring room if they needed help. No patients expressed exhaustion or 
discomfort, and it can only be assumed that their needs were taken care of. Nevertheless, 
shortening the time to accommodate the patients could have yielded a higher participant num-
ber, or for the purpose of the ALMUTH study, lessen the drop-out rate if applicable. 
All measures used here is well established and has shown to have both good reliability 
and validity. Some measures, however, have proved difficult employing on AD patients. As 
mentioned previously, some researchers have reported AD patients having trouble understand-
ing the directions of the SPPB (Pitkälä et al., 2013). A measure of physical performance de-
veloped specifically for this patient group is thus desired. Nonetheless, our patients were in an 
early stage of the disease, and no patients expressed difficulty understanding any SPPB direc-
tions. Further, it would be interesting looking at the different subsets of the SPPB (gait speed, 
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chair stands, and tandem) and their independent relation with each cognitive measure and 
HCV, but due to an omission with the first few patients, it was only feasible to look at the to-
tal score. 
Using automated segmentation methods for hippocampal volumetry was necessary for 
this study. Although its validity and agreement with manual segmentation have been docu-
mented in various research (Cherbuin et al., 2009; Dewey et al., 2010; Morey et al., 2009; 
Pardoe et al., 2009; Shen et al., 2010; Tae et al., 2008), the manual ‘gold standard’ will always 
be the best way to determine HCV for MR images. It has been reported in one study on man-
ual vs. automated segmentation that the mean HCV is larger with the FreeSurfer package than 
with manual segmentation (Tae et al., 2008). Looking through the literature on reported mean 
HCVs, both for healthy elderly, and AD patients, it is evident that the mean reported here of 
approximately 6 cm3 is larger than what is reported elsewhere with manual hippocampal vol-
umetry. However, the data is consistent with other research using FreeSurfer and the recon-all 
pipeline, and because it has been reported to have good agreeableness with manual segmenta-
tion, it is assumed that these hippocampal measures correlate with other research. 
Theoretical Implications 
In recent years, researchers have looked at the relationship between physical perfor-
mance and AD. Because HCV is seen as one of the core biomarkers for converting from MCI 
to AD (Apostolova et al., 2006b; Devanand et al., 2007), finding ways to slow down the hip-
pocampal atrophy has been a topic of great interest. There is substantial research into pharma-
cological ways to slow down the progression of AD, but recently, non-pharmacological ap-
proaches has emerged as a topic-of-interest. This study have shown that there might be a link 
between hippocampal atrophy and physical performance. In the literature, there is a general 
agreement that physical performance is beneficial to both physical and mental health (US De-
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partment of Health and Human Services, 2000; Whitmer et al., 2005a; Whitmer et al., 2005b), 
and to some degree, on subregions of the brain (Burns et al., 2008; Niemann et al., 2014), 
such as the hippocampus and the findings of this study supports this. The results showed a 
positive correlational association, albeit non-significant. This could be due to the small sam-
ple size but proves itself as important findings as a pilot study for the ALMUTH project. 
The findings here suggest a correlational relationship between depressive symptoms 
and HCV, confirming the general agreement in the literature (Erickson et al., 2012; Geerlings 
et al., 2008; Jacobson & Sapolsky, 1991; Jorm, 2001). Because depression often is seen in AD 
patients, finding solutions to treat depression is crucial for a better quality of life. The findings 
here did not suggest a strong relationship between physical performance and depression. This 
could be due to this thesis not comparing previous depressive episodes to present depressive 
symptoms. The literature suggests that there is an association between the two, and it can be 
assumed that these findings will differ with the ALMUTH project. Nonetheless, the findings 
on HCV and depression will withal be a positive contribution to studies linking HCV and de-
pression. 
In their systematic review in trying to find good-quality non-pharmacological ap-
proaches to treating dementia, Hulme and colleagues (2010) found that physical exercise is 
one of the most effective ways to treat dementia. Here, they concluded that there are too few 
high-quality studies on this topic, and most research looking at hippocampal atrophy and 
physical performance stems from animal research. There have also been a few clinical trials 
showing favorable effects of physical performance on memory, but most of these findings are 
also derived from animals (for review see Ang & Gomez-Pinilla, 2007 and; Cotman & Berch-
told, 2002). The findings from this study will serve as pilot data for the grand ALMUTH 
project which will hopefully yield promising contributions to the literature on the elderly 
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population, especially on AD patients. Hopefully, the ALMUTH study will come forward 
with excellent longitudinal data on how the brain, and specifically the hippocampus, is affect-
ed by physical performance. Furthermore, the project can contribute to the literature on how 
to help AD patients stay at home longer by finding good intervention strategies.  
Practical Implications 
Burns and colleagues (2008) found in their study that higher levels of physical per-
formance in early-onset AD patients were associated with less brain atrophy. Seeing positive 
results between physical performance and hippocampal atrophy here will prove important in 
the future of the ALMUTH project. Patients from this pilot study have been randomly as-
signed to one of three one-year intervention groups, one of which is physical exercise. Be-
cause an interesting association between SPPB and HCV has been seen here, it is recom-
mended that the researchers of the ALMUTH project should pursue the effect of physical per-
formance on hippocampal atrophy. The findings from the project will be shared with Bergen 
Municipality to find more effective ways to non-pharmacological treatments of dementia in 
and around the Bergen area. Seeing these promising results with such a small sample size is 
substantial, and can prove to become important for the grand project in the future. Because 
the ALMUTH project will look at both healthy controls and AD patients, it will become easier 
to draw conclusions on the effect of exercise and physical performance on hippocampal atro-
phy, and possibly disease progression. Moreover, a clear link between falls, balance and exer-
cise has come forward from Bergen Municipality report «Trygg på to bein» (Bergen Kom-
mune, 2010) amongst other research. The literature suggests that effects from physical exer-
cise can help reduce falls, and thus lengthy hospitalizations, by 30%. These results were 
found even for patients with established functional failure, such as patients scoring low on the 
SPPB (Campbell et al., 1999; Helbostad et al., 2007; Skelton et al., 2005). Although this the-
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sis did not screen for falls and lengthy hospital stays, it can be assumed through the literature 
that the patients scoring low on the SPPB will be more prone to this. If physical intervention 
can help AD patients, especially for patients scoring low on the SPPB in the current research 
project, it could have a substantial effect on these patients’ quality of life. 
Future Research 
The scientific literature on hippocampal atrophy and AD patients suggest HCV is usu-
ally smaller already at the MCI stage (Shi et al., 2009; van der Flier et al., 2005). Future re-
search should, therefore, include healthy controls to capture differences employing automated 
segmentation from the FreeSurfer software. Because such automated measures of hippocam-
pal volumetry using FreeSurfer yields larger HCV than with manual segmentation, it is im-
portant to look at how AD patients differ from healthy controls when using this method. Fu-
ture research should also include looking at the subregions of the hippocampus, as research 
suggests that mainly the left hippocampus, the CA1 and CA2, and the subiculum is greatly 
affected by AD. Seeing whether this atrophy can be altered through physical exercise could 
be eminently valuable. 
There was found a strong relationship for depressive symptoms and HCV, indicating 
that more depressed patients had lower HCV. Alzheimer’s disease patients often present with 
depressive symptoms and links have been made between hippocampal atrophy, depression, 
and dementia. The literature generally agrees upon a history of depression, rather than present 
depressive symptoms, are associated with AD, and future research should include the history 
of previous depressive episodes of both the patient and their close family. 
For AD patients, any task can seem excessive. The patients in the ALMUTH study 
needs to go through a long test battery, and for any healthy individual, up to three hours of 
testing is very long. Even so, including all tests in the test battery is necessary to ensure full 
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research benefits. An easy way to cut down time would be to employ the GDS-15 instead of 
the longer 30-question scale. The correlation between the two tests is very strong, and there 
should be no need to utilize the GDS-30 with an already long set of tests. Moreover, the GDS 
has been criticized for not being adequate in testing AD patients (Müller-Thomsen et al., 
2005). In the future, one should look at other, more AD adapted, tests - especially for longitu-
dinal studies with AD patients such as the ALMUTH project where patients cognition tend to 
deteriorate rapidly. 
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Conclusions 
The findings from this thesis have shown that there could be a relationship between 
HCV and physical performance. Hippocampal atrophy is seen as one of the core biomarkers 
for converting to AD, and although it is not possible to see causal relationships from the cur-
rent study, the ALMUTH project could provide valuable contributions to the literature with 
regard to hippocampal atrophy and exercise. Because they will test the patients over time (be-
fore, during, and after intervention), and use data of healthy controls, seeing how HCV chan-
ges over time with physical exercise intervention is possible. Moreover, a strong relationship 
between HCV and depressive symptoms was found. One goal of the ALMUTH study should 
be to, through improving physical performance, lessen patients’ depressive symptoms. A pos-
sibility could be that through exercise, physical performance will increase, and thus hippo-
campal atrophy will slow down. Even though the literature suggests a significant relationship 
between past depressive episodes and conversion to AD, helping patients with current depres-
sive symptoms through increasing physical performance could be consequential in helping 
these patients live more independently. 
Consequently, improving physical performance through exercise has been shown to 
benefit various comorbid disorders for AD patients, such as general physical health, diabetes, 
cardiovascular problems, diabetes, and obesity. It has also been seen to improve mental health 
illnesses, such as anxiety and depression. A few studies have pointed out that dementia is lin-
ked to such health issues, and by increasing physical performance in AD patients, comorbid 
risk factors might go away all-together, and possibly slow down the progression of AD. The 
goal of this study, and consequently the ALMUTH project, is to help AD patients live inde-
pendently at home longer, and this thesis has shown that the positive effects of physical per-
formance could be substantial in this goal. Finding ways to either slow down hippocampal 
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atrophy or ultimately, reverse it, could be momentous for this already vulnerable group of pa-
tients. The further investigation of the relationship between SPPB and HCV in AD patients is 
therefore recommended for the ALMUTH project. 
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Appendix B - Mini-Mental State Examination (MMSE)
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Appendix C - Activities of Daily Living (I-ADL & P-ADL) 
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